DuPont stock analysis
DuPont passes 5 of 8 fundamental tests, a score of 6/10. On the daily chart it is in an downtrend, RSI 48, 17% below its 52-week high: downtrend rally into the 20-day average. Its own volatility puts the likely range at $119.70–$142.17 a month from now and $96.83–$175.74 in a year (68% bands).
Fundamentals 6/10
- Market cap
- $17.6 B
- P/E · forward
- 35.1 · 16.3
- PEG · P/B
- 1.7 · 1.3
- ROE · net margin
- +2% · +1%
- Revenue · earnings growth
- +4% · +150%
- Debt / equity
- 23%
- Dividend · beta
- 1.8% · 1.1
- Next results
- 3 Nov 2026
- ✕ ROE above 15%
- ✕ Net margin above 10%
- ✕ Revenue growing over 10%
- ✓ Earnings growing
- ✓ Debt/equity under 100%
- ✓ Positive free cash flow
- ✓ Forward P/E under trailing (earnings expected up)
- ✓ PEG under 2
Swing technicals (daily)
- Trend
- down · 50d below 200d
- RSI(14)
- 48
- 20 / 50 / 200-day avg
- $130.58 / $133.46 / $138.04
- 20-day breakout
- above $134.00 · below $127.55
- ATR(14)
- $2.64 (2.0% a day)
- 52-week range
- $97.34 – $157.98
- Return 3m · 6m · 1y
- -4% · -8% · +31%
What the price could do
| In | Likely range (68%) |
|---|---|
| 1 mo | $119.70 – $142.17 (-8% / +9%) |
| 3 mo | $112.39 – $151.41 (-14% / +16%) |
| 6 mo | $105.66 – $161.05 (-19% / +23%) |
| 1 year | $96.83 – $175.74 (-26% / +35%) |
Analysts (17): buy, mean target $165.47 (+27%)
From its own volatility (30% a year), no drift assumed: what its swings allow, not a forecast.
DuPont news · last two days
News lean: Neutral- 2d agoRBC Cuts Price Target on DuPont de Nemours to $160 From $176, Keeps Outperform RatingMT Newswires
- 3d agoBet on the Winning DuPont Analysis & Pick 5 Top StocksZacks
- 4d agoDuPont Announces Regular Quarterly Dividend on Common StockPR Newswire
- 5d agoJPMorgan Downgrades DuPont de Nemours to Neutral From Overweight $145 Price TargetMT Newswires
Its order flow and footprint, the AI read of every headline, the expected move, and your own holdings beside it, with your broker connected.
Information and analytics for education only, not investment advice or a recommendation to buy or sell. Alephix Intelligence is not registered with SEBI as an investment adviser or research analyst. Prices may be delayed; figures come from public market data.